BIOMARKERS FOR ENDOMETRIAL CANCER

Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated gynecological samples by detecting the level of expression of one or more proteins. In particular from fluid samples of the female genital tract.The invention also provides kits comprising...

Full description

Saved in:
Bibliographic Details
Main Authors CABRERA DÍAZ, Silvia, GIL MORENO, Antonio, COLL DE LA RUBIA, Eva, DITTMAR, Gunnar Alfred Günther, COLAS ORTEGA, Eva, MARTINEZ GARCIA, Elena
Format Patent
LanguageEnglish
Published 15.02.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated gynecological samples by detecting the level of expression of one or more proteins. In particular from fluid samples of the female genital tract.The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.
Bibliography:Application Number: AU20220315559